<SEC-DOCUMENT>0001193125-18-127597-index.html : 20180424
<SEC-HEADER>0001193125-18-127597.hdr.sgml : 20180424
<ACCEPTANCE-DATETIME>20180424061603
ACCESSION NUMBER:		0001193125-18-127597
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20171231
FILED AS OF DATE:		20180424
DATE AS OF CHANGE:		20180424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		18770017

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>d550701d10ka.htm
<DESCRIPTION>10-K/A
<TEXT>
Document 1 - file: d550701d10ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>2
<FILENAME>d550701dex1040.htm
<DESCRIPTION>EX-10.40
<TEXT>
Document 2 - file: d550701dex1040.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>3
<FILENAME>d550701dex313.htm
<DESCRIPTION>EX-31.3
<TEXT>
Document 3 - file: d550701dex313.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>4
<FILENAME>d550701dex314.htm
<DESCRIPTION>EX-31.4
<TEXT>
Document 4 - file: d550701dex314.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g550701g0420111216653.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g550701g0420111216653.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g550701st_872.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g550701st_872.jpg

</DOCUMENT>
</SEC-DOCUMENT>